NET PROFIT (x1000 DKK)
EMPLOYEES
Biocrine AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
35
|
3
|
24 |
| Earnings before taxes |
-5,910
|
-6,584
|
-4,978 |
| EBITDA |
-5,897
|
-6,625
|
-4,959 |
| Total assets |
9,187
|
8,930
|
14,102 |
| Current assets |
1,131
|
287
|
6,364 |
| Current liabilities |
893
|
2,438
|
1,092 |
| Equity capital |
8,294
|
6,492
|
13,010 |
| - share capital |
193
|
191
|
181 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.3%
|
72.7%
|
92.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-63.9%
|
-73.7%
|
-35.1% |
| Current ratio |
126.7%
|
11.8%
|
582.8% |
| Return on equity (ROE) |
-71.3%
|
-101.4%
|
-38.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.